AU1544297A - A drug form which is formed in situ for delivering enzymes to wounds - Google Patents

A drug form which is formed in situ for delivering enzymes to wounds

Info

Publication number
AU1544297A
AU1544297A AU15442/97A AU1544297A AU1544297A AU 1544297 A AU1544297 A AU 1544297A AU 15442/97 A AU15442/97 A AU 15442/97A AU 1544297 A AU1544297 A AU 1544297A AU 1544297 A AU1544297 A AU 1544297A
Authority
AU
Australia
Prior art keywords
wounds
situ
drug form
delivering enzymes
enzymes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU15442/97A
Other versions
AU715587B2 (en
Inventor
Uwe Loffler
Thomas Moest
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott GmbH and Co KG
Original Assignee
Knoll GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll GmbH filed Critical Knoll GmbH
Publication of AU1544297A publication Critical patent/AU1544297A/en
Assigned to KNOLL AKTIENGESELLSCHAFT reassignment KNOLL AKTIENGESELLSCHAFT Alteration of Name(s) of Applicant(s) under S113 Assignors: NORDMARK ARZNEIMITTEL GMBH
Application granted granted Critical
Publication of AU715587B2 publication Critical patent/AU715587B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
AU15442/97A 1996-01-23 1997-01-22 A drug form which is formed in situ for delivering enzymes to wounds Ceased AU715587B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19602208A DE19602208A1 (en) 1996-01-23 1996-01-23 Pharmaceutical form formed in situ for the delivery of enzymes to wounds
DE19602208 1996-01-23
PCT/EP1997/000284 WO1997026861A1 (en) 1996-01-23 1997-01-22 Medicament forms constituted in situ for releasing enzymes into wounds

Publications (2)

Publication Number Publication Date
AU1544297A true AU1544297A (en) 1997-08-20
AU715587B2 AU715587B2 (en) 2000-02-03

Family

ID=7783390

Family Applications (1)

Application Number Title Priority Date Filing Date
AU15442/97A Ceased AU715587B2 (en) 1996-01-23 1997-01-22 A drug form which is formed in situ for delivering enzymes to wounds

Country Status (14)

Country Link
EP (1) EP0876139A1 (en)
JP (1) JP2001518063A (en)
KR (1) KR19990081901A (en)
CN (1) CN1209739A (en)
AU (1) AU715587B2 (en)
BR (1) BR9707058A (en)
CA (1) CA2243528A1 (en)
CZ (1) CZ230198A3 (en)
DE (1) DE19602208A1 (en)
HU (1) HUP9900942A3 (en)
IL (1) IL125148A (en)
NO (1) NO983373L (en)
WO (1) WO1997026861A1 (en)
ZA (1) ZA97514B (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2194144B (en) * 1986-08-22 1990-04-25 American Cyanamid Co Stable pharmaceutical gel preparation
US5580856A (en) * 1994-07-15 1996-12-03 Prestrelski; Steven J. Formulation of a reconstituted protein, and method and kit for the production thereof

Also Published As

Publication number Publication date
KR19990081901A (en) 1999-11-15
EP0876139A1 (en) 1998-11-11
HUP9900942A3 (en) 2000-06-28
CN1209739A (en) 1999-03-03
CZ230198A3 (en) 1999-02-17
JP2001518063A (en) 2001-10-09
BR9707058A (en) 1999-07-20
DE19602208A1 (en) 1997-07-24
NO983373L (en) 1998-09-21
IL125148A0 (en) 1999-01-26
ZA97514B (en) 1998-07-22
AU715587B2 (en) 2000-02-03
HUP9900942A2 (en) 1999-08-30
NO983373D0 (en) 1998-07-22
CA2243528A1 (en) 1997-07-31
WO1997026861A1 (en) 1997-07-31
IL125148A (en) 2001-03-19

Similar Documents

Publication Publication Date Title
AU7245898A (en) Methods and devices for delivering opioid analgesics to wounds
AU1728797A (en) Comforter for delivering medicine
AU6880500A (en) Production/injection line and methods relating to same
ZA988421B (en) A novel composition for controlled and sustained transdermal administration
AU3133097A (en) Chitosan related compositions for delivery of nucleic acids into a cell
AUPN605795A0 (en) Analgesic pharmaceutical composition
IL131229A (en) Compounds having enzymatic conversion inhibition for therapeutic intervention in preventing diabetic complications, pharmaceutical preparations and uses thereof
AU8695698A (en) Pharmacologic drug combination in vagal-induced asystole
AU1008597A (en) Enhanced accumulation of trehalose in plants
HUP0004491A3 (en) Isoqunolines as urokinase inhibitors process for producing them and use of them in the manufacture of a medicament
AU1865199A (en) Composition and method for dermal and transdermal administration of a cytokine
AU5158298A (en) Use of phenylcyclopropylamines to stimulate tear secretion
AU4407797A (en) Pharmaceutical composition forming a gel
AU2345695A (en) Pharmaceutical composition for transdermal delivery
GB9614452D0 (en) Improvements relating to pharmaceutical cartons
AU4437696A (en) Enhanced accumulation of trehalose in plants
AU4402197A (en) A gene related to migraine in man
IL138051A0 (en) Pharmaceutical formulation containing a hyaluronic acid-splitting enzyme of microbial origin
AU3041697A (en) Method of making a contact to a diamond
AU2620600A (en) Composition of anti-hiv drugs and anti-cortisol compounds and method for decreasing the side effects of anti-hiv drugs in a human
AU3100297A (en) Improvements in or relating to concrete structures
AU1544297A (en) A drug form which is formed in situ for delivering enzymes to wounds
AU7374396A (en) Use of sphingosylphosphorylcholine as a wound-healing agent
AU8047298A (en) Method for arrangement of a buried capacitor, and a buried capacitor arranged according to said method
AU3741997A (en) A novel human mrna editing enzyme

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired